858 Therapeutics uses CDD Vault

24 Oct 2023

In this case study, explore how 858 Therapeutics, a biotechnology and drug discovery company developing a portfolio of small molecule drugs that act on novel therapeutic targets in oncology, has deployed the CDD Vault® from Collaborative Drug Discovery, Inc. to manage its internal and external biological and chemical data.

Links

Tags